[Federal Register Volume 84, Number 129 (Friday, July 5, 2019)]
[Notices]
[Pages 32179-32180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14298]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-19MM]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Study on Disparities in Distress Screening
among Lung and Ovarian Cancer to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on March 6, 2019 to obtain comments from the public and affected
agencies. CDC did not receive comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202)
[[Page 32180]]
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Study on Disparities in Distress Screening among Lung and Ovarian
Cancer--New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP) Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Within the cancer treatment community, interest in the psychosocial
impacts of cancer diagnosis and treatment is increasing. These
psychosocial impacts are wide ranging and include not only anxiety
related to the illness and treatment side effects such as pain, fatigue
and cognition, but also stress related to nonmedical issues such as
family relationships, financial hardship, social stressors (e.g.
transportation), and stigmatization. There is growing evidence that
addressing the psychosocial stresses of cancer survivors increases both
their longevity and quality of life.
The 2016 Institute of Medicine (currently, National Academies of
Sciences, Engineering, and Medicine) ovarian cancer report, funded by
CDC, calls for increased study of the psychosocial needs of ovarian
cancer survivors, recognizing the high rates of depression, anxiety,
and distress. Up to 60% of lung cancer survivors also experience high
levels of distress. Both ovarian and lung cancer patients have
relatively low five-year survival rates (45% and 17%, respectively).
Therefore, CDC believes that it is imperative to develop a greater
understanding about the types of psychosocial services they receive
during their course of treatment and follow-up care.
CDC proposes a new information collection to examine the extent to
which disparities exist in distress screening and follow-up among
cancer treatment facilities and programs across the country. The study
will include 50 healthcare facilities. From these facilities, we will
request existing electronic health records (EHR) of 2,000 lung and
ovarian cancer survivors. Data elements collected will include patient
demographic information, cancer diagnosis and treatment, experience
with distress screening and follow-up care, and medical service
utilization. Patient names, addresses, birth dates and Social Security
Numbers will not be collected.
Staff from twelve of the 50 participating healthcare facilities
will be invited to participate in an interview and focus group to
provide contextual understanding about facilitators and barriers to
distress screening and follow-up processes. This is a one-time data
collection.
Results of this study will provide CDC's National Comprehensive
Cancer Control Program (NCCCP) with information to assist with the
development of information, resources, technical assistance, and future
evidence-based interventions to improve the quality of life of lung and
ovarian cancer survivors. Summative findings will be used to evaluate
the need to help with policy, systems, or environmental changes that
may enhance the landscape of quality of life services for cancer
survivors in communities at large. OMB approval is requested for one
year. The total estimated annualized burden hours are 512.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Instrument respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Quantitative:
Healthcare Professionals (POC).... Survey.................. 50 1 20/60
IT Staff.......................... EMR data................ 50 1 7.5
Qualitative:
Healthcare Professionals.......... Key Informant Interview. 12 1 1
Focus Groups............ 72 1 1.5
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-14298 Filed 7-3-19; 8:45 am]
BILLING CODE 4163-18-P